Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Accenture
Cantor Fitzgerald
Moodys
Cipla
Healthtrust
US Army
Boehringer Ingelheim
Merck

Generated: April 20, 2018

DrugPatentWatch Database Preview

IRON DEXTRAN Drug Profile

« Back to Dashboard

When do Iron Dextran patents expire, and when can generic versions of Iron Dextran launch?

Iron Dextran is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in IRON DEXTRAN is iron dextran. There are seventy-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the iron dextran profile page.
Summary for IRON DEXTRAN
Drug patent expirations by year for IRON DEXTRAN
Synonyms for IRON DEXTRAN
9004-66-4
A 100
A 100 (Pharmaceutical)
AC1L2XZQ
AC1LAX7G
AKOS030243004
American Regent Brand of Iron-Dextran Complex
B 75
Chinofer
Conferon
CTK8G0362
D08OKJ
Dexferrum
Dextran iron complex
Dextran-Iron Complex
Dextrofer
Dextrofer 75
EINECS 233-336-3
Eisendextran
Eisendextran [German]
Fe-Dextran
FeH2O4S
Fenate
Ferdex 100
Fero Gradumet
Ferric dextran
Ferridextran
Ferrodextran
Ferroglucin
Ferroglukin 75
FT-0624534
GlaxoSmithKline Brand of Iron-Dextran Complex
Goldline Brand of Iron-Dextran Complex
Hauck Brand of Iron-Dextran Complex
Hawthron Brand of Iron-Dextran Complex
Hematran
Icar
Imfergen
Imferon
Imperon
Imposil
IN003673
IN018759
IN019714
Iro-Jex
Iron dextran complex
Iron dextran injection
Iron hydrogenated dextran
Iron-Dextran
Iron-dextran complex
iron; sulfuric acid
Ironorm injection
K629
KS-00000XZM
Myofer 100
Norferan
NSC-146177
NSC-57631
NSC146177
NSC57631
Polyfer
Proferdex
Prolongal
Sanofi Brand of Iron-Dextran Complex
SULFURIC ACID IRON
Sulfuric acid iron salt (1:1)
Sulfuric acid iron(2+) salt (1:1)
Sulfuric acid, iron salt
Sulfuric acid, iron salt (1:?)
Sulfuric acid, iron salt (1:)
Sulphuric acid, iron salt
Ursoferran
Vortech Brand of Iron-Dextran Complex
Watson Brand of Iron-Dextran Complex
WLN: FE S-O4

US Patents and Regulatory Information for IRON DEXTRAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us IRON DEXTRAN iron dextran INJECTABLE;INJECTION 010787-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
Dow
Daiichi Sankyo
Farmers Insurance
Federal Trade Commission
Accenture
Medtronic
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.